Table Of Contents
1 Introduction 19
1.1 Objectives Of The Study 19
1.2 Market Definition 19
1.3 Overview Of North America Angioplasty Balloons Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 Secondary Sources 30
2.8 Assumptions 30
3 Market Overview 31
3.1 Drivers 33
3.1.1 Growing Incidences Of Target Disease 33
3.1.2 New Product Innovations 34
3.1.3 Technological Advancement In Cardiovascular Disease Treatment 35
3.1.4 Rising Number Of Geriatric Population 36
3.2 Restraints 36
3.2.1 Increase In Number Of Market Players 36
3.2.2 Price Clash Due To Increase In The Number Of Market Players 37
3.3 Opportunities 38
3.3.1 Mergers And Acquisitions 38
3.3.2 Growing Number Of Angioplasty Procedure 38
3.4 Challenges 39
3.4.1 Lack Of Trained Staff 39
4 Executive Summary 40
5 Premium Insights 43
6 North America Angioplasty Balloons Market, By Type 46
6.1 Overview 47
6.2 Plain Old Balloon Angioplasty (Poba) 49
6.3 Drug-Coated Balloon (Dcb) Angioplasty 50
6.4 Cutting Balloons 51
6.5 Scoring Balloons 52
6.6 Stent Graft Balloon Catheter 53
7 North America Angioplasty Balloons Market, By Material 54
7.1 Overview 55
7.2 Nylon 57
7.3 Polyurethane 58
7.4 Silicone Urethane Co-Polymers 59
7.5 Other 60
8 North America Angioplasty Balloons Market, By Balloon Type 61
8.1 Overview 62
8.2 Semi-Compliant 64
8.3 Non-Compliant 65
9 North America Angioplasty Balloons Market, By Disease Indication 66
9.1 Overview 67
9.2 Coronary Angioplasty 69
9.3 Peripheral Angioplasty 70
9.4 Carotid Angioplasty 71
9.5 Renal Artery Angioplasty 72
9.6 Venous Angioplasty 73
10 North America Angioplasty Balloons Market, By End User 74
10.1 Overview 75
10.2 Ambulatory Surgical Centers 77
10.3 Hospitals 78
10.4 Specialty Clinics 79
10.5 Diagnostic Centers 80
10.6 Cath Lab 81
11 North America Angioplasty Balloons Market By Geography 82
11.1 North America 82
11.1.1 U.S. 91
11.1.2 Canada 94
11.1.3 Mexico 97
12 North America Angioplasty Balloons Market, Company Landscape 100
12.1 Company Share Analysis; North America 100
13 Company Profiles 101
13.1 Medtronic 101
13.1.1 Company Overview 101
13.1.2 Revenue Analysis 101
13.1.3 Company Share Analysis (%) 102
13.1.4 Product Portfolio 102
13.1.5 Recent Developments 103
13.2 C. R. Bard, Inc. (Part Of Becton, Dickinson And Company) 104
13.2.1 Company Overview 104
13.2.2 Geographic Presence 104
13.2.3 Company Share Analysis (%) 105
13.2.4 Product Portfolio 105
13.2.5 Recent Developments 106
13.3 Boston Scientific Corporation 107
13.3.1 Company Overview 107
13.3.2 Revenue Analysis 107
13.3.3 Company Share Analysis (%) 108
13.3.4 Product Portfolio 108
13.3.5 Recent Developments 109
13.4 Abbott Laboratories 110
13.4.1 Company Overview 110
13.4.2 Revenue Analysis 110
13.4.3 Product Portfolio 111
13.4.4 Recent Developments 111
13.5 Angiodynamics, Inc. 112
13.5.1 Company Overview 112
13.5.2 Revenue Analysis 112
13.5.3 Product Portfolio 113
13.5.4 Recent Developments 113
13.6 B. Braun Melsungen Ag 114
13.6.1 Company Overview 114
13.6.2 Revenue Analysis 114
13.6.3 Product Portfolio 115
13.6.4 Recent Developments 115
13.7 Biomerics, Llc 116
13.7.1 Company Overview 116
13.7.2 Geographic Presence 116
13.7.3 Product Portfolio 117
13.7.4 Recent Developments 117
13.8 Biotronik Se & Co. Kg 118
13.8.1 Company Overview 118
13.8.2 Geographic Presence 118
13.8.3 Product Portfolio 119
13.8.4 Recent Developments 119
13.9 Cook Medical Incorporated 120
13.9.1 Company Overview 120
13.9.2 Geographic Presence 120
13.9.3 Product Portfolio 121
13.9.4 Recent Developments 121
13.10 Cordis Corporation 122
13.10.1 Company Overview 122
13.10.2 Geogrphic Presence 122
13.10.3 Product Portfolio 123
13.10.4 Recent Developments 124
13.11 Hexacath 125
13.11.1 Company Overview 125
13.11.2 Product Portfolio 125
13.11.3 Recent Developments 125
13.12 Jotec Ag 126
13.12.1 Company Overview 126
13.12.2 Revenue Analysis 126
13.12.3 Product Portfolio 127
13.12.4 Recent Developments 127
13.13 Koninklijke Philips N.V. 128
13.13.1 Company Overview 128
13.13.2 Revenue Analysis 128
13.13.3 Product Portfolio 129
13.13.4 Recent Developments 129
13.14 Microport Scientific 130
13.14.1 Company Overview 130
13.14.2 Revenue Analysis 130
13.14.3 Product Portfolio 131
13.14.4 Recent Developments 131
13.15 Nipro Medical Corporation 132
13.15.1 Company Overview 132
13.15.2 Revenue Analysis 132
13.15.3 Product Portfolio 133
13.15.4 Recent Developments 133
13.16 Palex Medical Sa 134
13.16.1 Company Overview 134
13.16.2 Geographic Presence 134
13.16.3 Product Portfolio 135
13.16.4 Recent Developments 135
13.17 Panmed Us 136
13.17.1 Company Overview 136
13.17.2 Product Portfolio 136
13.17.3 Recent Developments 137
13.18 Stryker 138
13.18.1 Company Overview 138
13.18.2 Revenue Analysis 138
13.18.3 Product Portfolio 139
13.18.4 Recent Developments 139
13.19 Teleflex Inororated 140
13.19.1 Company Overview 140
13.19.2 Revenue Analysis 140
13.19.3 Product Portfolio 141
13.19.4 Recent Developments 141
13.20 Terumo Corporation 142
13.20.1 Company Overview 142
13.20.2 Revenue Analysis 142
13.20.3 Product Portfolio 143
13.20.4 Recent Developments 144
14 Latest Reports 145
?